Dutch startup providing a remote-monitoring platform for chronic and post-acute patients, used by hospitals and homecare providers.
Luscii occupies a strong niche position in the European digital health market, specifically within the Netherlands and surrounding regions, focusing on user-friendly remote monitoring for chronic and post-acute care.
Market Share: While specific market share data is not public, Luscii is a recognized leader in the Dutch digital health sector for remote monitoring.
The remote patient monitoring market is highly competitive, characterized by a shift from simple telehealth to complex virtual ward and hospital-at-home models. The landscape includes both large medical device corporations and agile digital health startups.
A global incumbent offering comprehensive remote patient monitoring solutions that often integrate with broader hospital infrastructure.
Strengths
Weaknesses
A UK-based virtual ward provider that focuses on 'hospital at home' models, similar to Luscii's clinical focus.
Strengths
Weaknesses
A Best Buy Health company providing a sophisticated remote patient monitoring platform that combines wearable tech with clinical software.
Strengths
Weaknesses
Focuses on clinical AI and remote monitoring to improve patient care pathways.
Strengths
Weaknesses
Strong clinical partnerships
High patient engagement rates due to intuitive interface
Agile development process allowing for rapid feature updates
Proven track record in reducing hospital readmission rates
Rapid consolidation by large healthcare technology firms
Increasingly stringent EU medical device regulations (MDR)
Pressure on healthcare budgets limiting long-term adoption
Competition from generalist telehealth platforms expanding into monitoring
Add anonymous, community-submitted insights for this company section.
Loading contributions...